Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis
NCT06476366Phase 1Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in chronic actinic dermatitis (CAD) comparing Methotrexate arm with Azathioprine (2 arms). Primary endpoint: 50% Reduction in the Eczema Area and Severity Index Score at 6 months. Started Jul 2024; status: completed.
02
Drugs
methotrexateazathioprine
03
Conditions
chronic actinic dermatitis (CAD)
Beyond the preview
Go deeper on NCT06476366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06476366.